Common Contracts
1 similar null contracts
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYJune 2nd, 2022
Sponsor / Study Title: Pfizer Inc / “A PHASE 1, RANDOMIZED, DOUBLE-BLIND, SPONSOR OPEN, PLACEBO-CONTROLLED, DOSE ESCALATING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SINGLE AND MULTIPLE INTRAVENOUS AND SUBCUTANEOUS DOSES OFPF-07275315 IN HEALTHY PARTICIPANTS” Part A - SINGLE DOSE Protocol Number: C4531001 Principal Investigator: Sylvester Pawlak, APRN Telephone 24 Hours: 203-401-0300 Address: New Haven Clinical Research Unit One Howe StNew Haven, CT 06511
